Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis 2017-01-01
  2. A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia 2011-03-31
  3. Antidepressants for agitation and psychosis in dementia 2011-02-16

Studies

4 studies carry this tag.

Date range

2007 to 2017

Top journals

  • Journal of Alzheimer's disease : JAD 1
  • Journal of the American Geriatrics Society 1
  • Pharmacology & therapeutics 1
  • The Cochrane database of systematic reviews 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis

    ✓ Peer-reviewed alzhub usefulness score 78 out of 100. Journal of Alzheimer's disease : JAD 2017-01-01 Clinical trials

    Despite the importance of depression in people with AD, few RCTs are available on efficacy of antidepressants, limiting clear conclusions of their potential role.

  2. A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Journal of the American Geriatrics Society 2011-03-31 Clinical trials

    The evidence for antidepressant treatment of people with depression and dementia, although suggestive, does not confirm efficacy.

  3. Antidepressants for agitation and psychosis in dementia

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. The Cochrane database of systematic reviews 2011-02-16 Treatments

    Selection criteria Randomized, controlled trials of antidepressants (selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, trazodone, and other antidepressants), compared to either placebo or comparator medications (typical or atypical antipsychotics, anticonvulsants, benzodiazepines, cholinesterase inhibitors, memantine or other medications) for treatment of agitation or psychosis in older adults with dementia.

  4. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Pharmacology & therapeutics 2007-08-15 Prevention trials

    The focus of this review is to critically examine and review the literature on the role of brain-derived neurotrophic factor (BDNF) and its primary receptor, tropomyosin-related kinase B (TrkB), in the actions of pharmacologically diverse antidepressant treatments for depression.

All topic tags with their study counts